Anand Kumaresh Tharmaratnam
Chairman bei Novotech Holdings Pty Ltd.
Profil
Anand Kumaresh Tharmaratnam is currently the Chairman of Novotech (Australia) Pty Ltd., Novotech Holdings Pty Ltd., and Novotech Health Holdings Ltd.
He is also a Director at Pathology Asia Holdings Pte Ltd.
and Askdrt Ltd.
In the past, he held senior positions at IQVIA RDS Asia, Inc., IQVIA RDS, Inc., and IQVIA Holdings, Inc. He is a member of the Royal College of Anaesthetists.
Dr. Tharmaratnam received his doctorate degree from University College London in 1992.
Aktive Positionen von Anand Kumaresh Tharmaratnam
| Unternehmen | Position | Beginn |
|---|---|---|
Novotech Holdings Pty Ltd.
 Novotech Holdings Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Novotech Health Holdings engages in the development of contract research organization platform. The company was founded on October 12, 2020 and is headquartered in Australia. | Chairman | 01.04.2021 |
Novotech Health Holdings Ltd.
 Novotech Health Holdings Ltd. BiotechnologyHealth Technology Novotech Health Holdings Ltd. operates as a biotech-focused full-service contract research organization. Its integrated CRO platform provides clinical trial services ranging from consulting services prior to the commencement of the clinical phase to late-phase clinical trials. The firm’s services include: clinical trial services which include clinical research, bioequivalence and pharmacodynamics research, and drug development consulting services; and its related clinical trial services which include laboratory, site management organization, flexible insourcing and Phase I clinical trial unit services. The company was founded on February 25, 2020 and is headquartered in Singapore. | Chairman | 01.04.2021 |
| Askdrt Ltd. | Director/Board Member | 01.04.2020 |
| Royal College of Anaesthetists | Corporate Officer/Principal | 01.08.1995 |
Novotech (Australia) Pty Ltd.
 Novotech (Australia) Pty Ltd. BiotechnologyHealth Technology Novotech (Australia) Pty Ltd. operates as a contract research organization. It provides clinical development services across all clinical trial phases and therapeutic areas including: feasibility assessments; ethics committee and regulatory submissions, data management, statistical analysis, medical monitoring, safety services and central lab services. The firm offers patient recruitment and site selection, clinical operations and project management, medical and regulatory consulting, biometrics and data management solutions. The company was founded by Alek Safarian in 1996 and is headquartered in Sydney, Australia. | Chairman | - |
Pathology Asia Holdings Pte Ltd.
 Pathology Asia Holdings Pte Ltd. Medical/Nursing ServicesHealth Services Pathology Asia Holdings Pte Ltd. operates as an holding company. The company was founded in 2018 and is headquartered in Singapore. | Director/Board Member | - |
Ehemalige bekannte Positionen von Anand Kumaresh Tharmaratnam
| Unternehmen | Position | Ende |
|---|---|---|
IQVIA RDS, Inc.
 IQVIA RDS, Inc. Miscellaneous Commercial ServicesCommercial Services IQVIA RDS, Inc. (North Carolina) provides solutions to the healthcare industry. The company was founded by Dennis B. Gillings in 1982 and is headquartered in Durham, NC. | Corporate Officer/Principal | - |
| IQVIA HOLDINGS INC. | President | - |
IQVIA RDS Asia, Inc.
 IQVIA RDS Asia, Inc. Pharmaceuticals: MajorHealth Technology IQVIA RDS Asia, Inc. provides clinical research services. It offers pharmacy, medical, equipment, clinical, diagnostics investigations, renal care, clinical laboratories, and teleradiology services. The company is headquartered in Durham, NC. | President | - |
Ausbildung von Anand Kumaresh Tharmaratnam
| University College London | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| IQVIA HOLDINGS INC. | Health Services |
| Private Unternehmen | 8 |
|---|---|
IQVIA RDS Asia, Inc.
IQVIA RDS Asia, Inc. Pharmaceuticals: MajorHealth Technology IQVIA RDS Asia, Inc. provides clinical research services. It offers pharmacy, medical, equipment, clinical, diagnostics investigations, renal care, clinical laboratories, and teleradiology services. The company is headquartered in Durham, NC. | Health Technology |
Novotech (Australia) Pty Ltd.
Novotech (Australia) Pty Ltd. BiotechnologyHealth Technology Novotech (Australia) Pty Ltd. operates as a contract research organization. It provides clinical development services across all clinical trial phases and therapeutic areas including: feasibility assessments; ethics committee and regulatory submissions, data management, statistical analysis, medical monitoring, safety services and central lab services. The firm offers patient recruitment and site selection, clinical operations and project management, medical and regulatory consulting, biometrics and data management solutions. The company was founded by Alek Safarian in 1996 and is headquartered in Sydney, Australia. | Health Technology |
IQVIA RDS, Inc.
IQVIA RDS, Inc. Miscellaneous Commercial ServicesCommercial Services IQVIA RDS, Inc. (North Carolina) provides solutions to the healthcare industry. The company was founded by Dennis B. Gillings in 1982 and is headquartered in Durham, NC. | Commercial Services |
Pathology Asia Holdings Pte Ltd.
Pathology Asia Holdings Pte Ltd. Medical/Nursing ServicesHealth Services Pathology Asia Holdings Pte Ltd. operates as an holding company. The company was founded in 2018 and is headquartered in Singapore. | Health Services |
Novotech Holdings Pty Ltd.
Novotech Holdings Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Novotech Health Holdings engages in the development of contract research organization platform. The company was founded on October 12, 2020 and is headquartered in Australia. | Commercial Services |
Novotech Health Holdings Ltd.
Novotech Health Holdings Ltd. BiotechnologyHealth Technology Novotech Health Holdings Ltd. operates as a biotech-focused full-service contract research organization. Its integrated CRO platform provides clinical trial services ranging from consulting services prior to the commencement of the clinical phase to late-phase clinical trials. The firm’s services include: clinical trial services which include clinical research, bioequivalence and pharmacodynamics research, and drug development consulting services; and its related clinical trial services which include laboratory, site management organization, flexible insourcing and Phase I clinical trial unit services. The company was founded on February 25, 2020 and is headquartered in Singapore. | Health Technology |
| Askdrt Ltd. | |
| Royal College of Anaesthetists |
